Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma-Reference-Cited by-同舟云学术

Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma

Published:2017-05-05 Issue:34 Volume:8 Page:56281-56295
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lin Chao¹,Yan HuaYing¹²,Yang Jun¹,Li Lei¹,Tang Mei¹,Zhao Xinyu¹,Nie Chunlai¹,Luo Na³,Wei Yuquan¹,Yuan Zhu¹

Affiliation:

1. State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, Sichuan University, Chengdu, 610041, China

2. Department of Functional Imaging, Sichuan Provincial Women's and Children's Hospital, Chengdu, 610031, China

3. Nankai University School of Medicine, Collaborative Innovation Center of Biotherapy, Tianjin, 300071, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent and selective activity-based probes (ABPs) for the deubiquitinating enzyme USP30;RSC Chemical Biology;2024

2. Recombinant Newcastle disease virus kills liver cancer in vitro and in vivo;Future Virology;2023-02

3. Changes in long non-coding RNA expression profiles related to the antagonistic effects of Escherichia coli F17 on lamb spleens;Scientific Reports;2018-11-08

4. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway;Pathology & Oncology Research;2018-11-08

5. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis;Experimental Cell Research;2018-10